Bo Feng
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 11
- Oncology top 2%
- Colorectal Cancer Surgical Treatments 37
- Colorectal Cancer Screening and Detection 15
- Molecular Biology top 5%
- RNA modifications and cancer 11
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment 8
-
- Gastric Cancer Management and Outcomes 20
-
- Colorectal and Anal Carcinomas 16
- Anorectal Disease Treatments and Outcomes 8
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Bo Feng
116 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 896
- Oncology 989
- Molecular Biology 1.6k
- Gastroenterology 85
- Pulmonary and Respiratory Medicine 486
Countries citing papers authored by Bo Feng
This map shows the geographic impact of Bo Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Feng more than expected).
Fields of papers citing papers by Bo Feng
This network shows the impact of papers produced by Bo Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Feng. The network helps show where Bo Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 20 | |
| 6 | 2021 | 16 | |
| 7 | 2020 | 18 | |
| 8 | 2020 | 21 | |
| 9 | 2017 | 21 | |
| 10 | 2016 | 2 | |
| 11 | 2016 | 1 | |
| 12 | WITHDRAWN: The association of serum parathyriod hormone and calcium levels with primary aldosteronism: a meta-analysis. | 2016 | 1 |
| 13 | 2016 | 12 | |
| 14 | 2014 | 35 | |
| 15 | 2014 | 7 | |
| 16 | 2012 | 97 | |
| 17 | 2010 | 39 | |
| 18 | 2010 | 1 | |
| 19 | 2009 | 10 | |
| 20 | 2007 | 26 |
About Bo Feng
Bo Feng is a scholar working on Oncology, Gastroenterology and Cancer Research, having authored 123 papers that have together received 2.8k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (37 papers), Gastric Cancer Management and Outcomes (20 papers), Colorectal and Anal Carcinomas (16 papers), Colorectal Cancer Screening and Detection (15 papers), RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (11 papers), Anorectal Disease Treatments and Outcomes (8 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). The work is most often cited by research in Cancer Research (896 citations), Oncology (989 citations) and Molecular Biology (1.6k citations). Bo Feng has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Minhua Zheng, Minhua Zheng, Aiguo Lu, Lu Zang, Jing Ping Sun, Sen Zhang, Taotao Dong, Pei Xue, Zirui He and Luyang Zhang. Their work appears in journals such as PLoS ONE, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.